Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy. - Ohba, Shigeo; Teranishi, Takao; Matsumura, Kazuyasu; Kumon, Masanobu; Kojima, Daijiro; Fujiwara, Eiji; Nakao, Kazutaka; Kuwahara, Kiyonori; Murayama, Kazuhiro; Pareira, Eriel Sandika; Yamada, Seiji; Joko, Masahiro; et al. (Scientific Reports, 2025)